May 4, 2018 / 11:26 AM / 2 months ago

BRIEF-Agios Qtrly Loss Per Share $1.63

May 4 (Reuters) - Agios Pharmaceuticals Inc:

* AGIOS PROVIDES BUSINESS UPDATE ON DISCOVERY RESEARCH STRATEGY AND PIPELINE, PROGRESS ON CLINICAL PROGRAMS, COMMERCIAL LAUNCH PREPARATIONS AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AT INVESTOR DAY

* Q1 REVENUE $8.8 MILLION VERSUS I/B/E/S VIEW $10.6 MILLION

* AGIOS PHARMA-SEES ENOUGH CASH,CASH EQUIVALENTS,MARKETABLE SECURITIES AS OF MARCH 31,AMONG OTHERS,TO FUND OPERATING EXPENSES,CAPEX THROUGH AT LEAST 2022 END

* QTRLY LOSS PER SHARE $1.63

* Q1 EARNINGS PER SHARE VIEW $-1.63 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below